APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Contraceptive Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Oral Contraceptive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025195 pages

Choose your research edition.

Industry ResearchOral Contraceptive Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Contraceptive Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Oral Contraceptive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Contraceptive Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Contraceptive Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Contraceptive Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Contraceptive Drugs include Teva Pharmaceutical, Johnson & Johnson, Baijingyu, Merck, Pfizer, Bayer, ZiZhu, Novo Nordisk A/S and Huazhong, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Contraceptive Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Contraceptive Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Contraceptive Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Contraceptive Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Contraceptive Drugs Segment by Company

Teva Pharmaceutical

Johnson & Johnson

Baijingyu

Merck

Pfizer

Bayer

ZiZhu

Novo Nordisk A/S

Huazhong

Gedeon Richter

Actavis

Oral Contraceptive Drugs Segment by Type

Short-acting Contraceptives

Emergency Contraceptives

Long-acting Contraceptives

Oral Contraceptive Drugs Segment by Application

Hospital

Pharmacy

Other

Oral Contraceptive Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contraceptive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Contraceptive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contraceptive Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Contraceptive Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Contraceptive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Oral Contraceptive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Oral Contraceptive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Oral Contraceptive Drugs Industry Trends Table 2. Oral Contraceptive Drugs Industry Drivers Table 3. Oral Contraceptive Drugs Industry Opportunities and Challenges Table 4. Oral Contraceptive Drugs Industry Restraints Table 5. Global Oral Contraceptive Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Oral Contraceptive Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Oral Contraceptive Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Oral Contraceptive Drugs Sales Market Share by Manufacturers Table 9. Global Oral Contraceptive Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Oral Contraceptive Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Oral Contraceptive Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Oral Contraceptive Drugs Manufacturers, Product Type & Application Table 13. Global Oral Contraceptive Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Contraceptive Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Short-acting Contraceptives Table 17. Major Manufacturers of Emergency Contraceptives Table 18. Major Manufacturers of Long-acting Contraceptives Table 19. Global Oral Contraceptive Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Oral Contraceptive Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Oral Contraceptive Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Oral Contraceptive Drugs Sales Market Share by Type (2021-2026) Table 23. Global Oral Contraceptive Drugs Sales Market Share by Type (2027-2032) Table 24. Global Oral Contraceptive Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Oral Contraceptive Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Oral Contraceptive Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Oral Contraceptive Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Oral Contraceptive Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Pharmacy Table 31. Major Manufacturers of Other Table 32. Global Oral Contraceptive Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Oral Contraceptive Drugs Sales by Application (2021-2026) & (K Units) Table 34. Global Oral Contraceptive Drugs Sales by Application (2027-2032) & (K Units) Table 35. Global Oral Contraceptive Drugs Sales Market Share by Application (2021-2026) Table 36. Global Oral Contraceptive Drugs Sales Market Share by Application (2027-2032) Table 37. Global Oral Contraceptive Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Oral Contraceptive Drugs Revenue by Application (2021-2026) & (K Units) Table 39. Global Oral Contraceptive Drugs Revenue by Application (2027-2032) & (K Units) Table 40. Global Oral Contraceptive Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Oral Contraceptive Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Oral Contraceptive Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Oral Contraceptive Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Oral Contraceptive Drugs Sales Market Share by Region (2021-2026) Table 45. Global Oral Contraceptive Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Oral Contraceptive Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Oral Contraceptive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 49. North America Oral Contraceptive Drugs Sales by Country (2027-2032) & (K Units) Table 50. Europe Oral Contraceptive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 52. Europe Oral Contraceptive Drugs Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Oral Contraceptive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Oral Contraceptive Drugs Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Oral Contraceptive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Oral Contraceptive Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Oral Contraceptive Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Oral Contraceptive Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Oral Contraceptive Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Oral Contraceptive Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Oral Contraceptive Drugs Revenue Market Share by Region (2027-2032) Table 64. Teva Pharmaceutical Company Information Table 65. Teva Pharmaceutical Business Overview Table 66. Teva Pharmaceutical Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Oral Contraceptive Drugs Product Portfolio Table 68. Teva Pharmaceutical Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Oral Contraceptive Drugs Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Baijingyu Company Information Table 75. Baijingyu Business Overview Table 76. Baijingyu Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Baijingyu Oral Contraceptive Drugs Product Portfolio Table 78. Baijingyu Recent Development Table 79. Merck Company Information Table 80. Merck Business Overview Table 81. Merck Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Merck Oral Contraceptive Drugs Product Portfolio Table 83. Merck Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Oral Contraceptive Drugs Product Portfolio Table 88. Pfizer Recent Development Table 89. Bayer Company Information Table 90. Bayer Business Overview Table 91. Bayer Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Bayer Oral Contraceptive Drugs Product Portfolio Table 93. Bayer Recent Development Table 94. ZiZhu Company Information Table 95. ZiZhu Business Overview Table 96. ZiZhu Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. ZiZhu Oral Contraceptive Drugs Product Portfolio Table 98. ZiZhu Recent Development Table 99. Novo Nordisk A/S Company Information Table 100. Novo Nordisk A/S Business Overview Table 101. Novo Nordisk A/S Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Novo Nordisk A/S Oral Contraceptive Drugs Product Portfolio Table 103. Novo Nordisk A/S Recent Development Table 104. Huazhong Company Information Table 105. Huazhong Business Overview Table 106. Huazhong Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Huazhong Oral Contraceptive Drugs Product Portfolio Table 108. Huazhong Recent Development Table 109. Gedeon Richter Company Information Table 110. Gedeon Richter Business Overview Table 111. Gedeon Richter Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Gedeon Richter Oral Contraceptive Drugs Product Portfolio Table 113. Gedeon Richter Recent Development Table 114. Actavis Company Information Table 115. Actavis Business Overview Table 116. Actavis Oral Contraceptive Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Actavis Oral Contraceptive Drugs Product Portfolio Table 118. Actavis Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Oral Contraceptive Drugs Distributors List Table 122. Oral Contraceptive Drugs Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Oral Contraceptive Drugs Product Image Figure 2. Global Oral Contraceptive Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Contraceptive Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Contraceptive Drugs Sales (2021-2032) & (K Units) Figure 5. Global Oral Contraceptive Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Oral Contraceptive Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Short-acting Contraceptives Image Figure 9. Emergency Contraceptives Image Figure 10. Long-acting Contraceptives Image Figure 11. Global Oral Contraceptive Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Oral Contraceptive Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Oral Contraceptive Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Oral Contraceptive Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Oral Contraceptive Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Oral Contraceptive Drugs Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Pharmacy Image Figure 19. Other Image Figure 20. Global Oral Contraceptive Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Oral Contraceptive Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Oral Contraceptive Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Oral Contraceptive Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Oral Contraceptive Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Oral Contraceptive Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Oral Contraceptive Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Oral Contraceptive Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Oral Contraceptive Drugs Sales Market Share by Country (2021-2032) Figure 40. China Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Oral Contraceptive Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Oral Contraceptive Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Oral Contraceptive Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Oral Contraceptive Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Oral Contraceptive Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Oral Contraceptive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Oral Contraceptive Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Oral Contraceptive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Oral Contraceptive Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Oral Contraceptive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Oral Contraceptive Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Oral Contraceptive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Oral Contraceptive Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Oral Contraceptive Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Short-acting Contraceptives
  • Emergency Contraceptives
  • Long-acting Contraceptives
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Teva Pharmaceutical
  • Johnson & Johnson
  • Baijingyu
  • Merck
  • Pfizer
  • Bayer
  • ZiZhu
  • Novo Nordisk A/S
  • Huazhong
  • Gedeon Richter
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Contraceptive Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Contraceptive Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Oral Contraceptive Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Oral Contraceptive Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Oral Contraceptive Drugs Market Dynamics
  1. 2.1 Oral Contraceptive Drugs Industry Trends
  2. 2.2 Oral Contraceptive Drugs Industry Drivers
  3. 2.3 Oral Contraceptive Drugs Industry Opportunities and Challenges
  4. 2.4 Oral Contraceptive Drugs Industry Restraints
3 Oral Contraceptive Drugs Market by Manufacturers
  1. 3.1 Global Oral Contraceptive Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Oral Contraceptive Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Oral Contraceptive Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Oral Contraceptive Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Contraceptive Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Oral Contraceptive Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Oral Contraceptive Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Contraceptive Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Contraceptive Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Contraceptive Drugs Tier 1, Tier 2, and Tier 3
4 Oral Contraceptive Drugs Market by Type
  1. 4.1 Oral Contraceptive Drugs Type Introduction
  2. 4.1.1 Short-acting Contraceptives
  3. 4.1.2 Emergency Contraceptives
  4. 4.1.3 Long-acting Contraceptives
  5. 4.2 Global Oral Contraceptive Drugs Sales by Type
  6. 4.2.1 Global Oral Contraceptive Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Oral Contraceptive Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Oral Contraceptive Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Oral Contraceptive Drugs Revenue by Type
  10. 4.3.1 Global Oral Contraceptive Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Oral Contraceptive Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Oral Contraceptive Drugs Revenue Market Share by Type (2021-2032)
5 Oral Contraceptive Drugs Market by Application
  1. 5.1 Oral Contraceptive Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Oral Contraceptive Drugs Sales by Application
  6. 5.2.1 Global Oral Contraceptive Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Contraceptive Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Oral Contraceptive Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Oral Contraceptive Drugs Revenue by Application
  10. 5.3.1 Global Oral Contraceptive Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Oral Contraceptive Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Oral Contraceptive Drugs Revenue Market Share by Application (2021-2032)
6 Global Oral Contraceptive Drugs Sales by Region
  1. 6.1 Global Oral Contraceptive Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Contraceptive Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Contraceptive Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Oral Contraceptive Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Contraceptive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Oral Contraceptive Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Oral Contraceptive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Oral Contraceptive Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Oral Contraceptive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Oral Contraceptive Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Oral Contraceptive Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Oral Contraceptive Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Oral Contraceptive Drugs Revenue by Region
  1. 7.1 Global Oral Contraceptive Drugs Revenue by Region
  2. 7.1.1 Global Oral Contraceptive Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Oral Contraceptive Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Oral Contraceptive Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Oral Contraceptive Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Oral Contraceptive Drugs Revenue (2021-2032)
  8. 7.2.2 North America Oral Contraceptive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Oral Contraceptive Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Oral Contraceptive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Oral Contraceptive Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Oral Contraceptive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Oral Contraceptive Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Oral Contraceptive Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Oral Contraceptive Drugs Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Oral Contraceptive Drugs Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Baijingyu
  14. 8.3.1 Baijingyu Company Information
  15. 8.3.2 Baijingyu Business Overview
  16. 8.3.3 Baijingyu Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Baijingyu Oral Contraceptive Drugs Product Portfolio
  18. 8.3.5 Baijingyu Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Oral Contraceptive Drugs Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Oral Contraceptive Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Oral Contraceptive Drugs Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 ZiZhu
  38. 8.7.1 ZiZhu Company Information
  39. 8.7.2 ZiZhu Business Overview
  40. 8.7.3 ZiZhu Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ZiZhu Oral Contraceptive Drugs Product Portfolio
  42. 8.7.5 ZiZhu Recent Developments
  43. 8.8 Novo Nordisk A/S
  44. 8.8.1 Novo Nordisk A/S Company Information
  45. 8.8.2 Novo Nordisk A/S Business Overview
  46. 8.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Product Portfolio
  48. 8.8.5 Novo Nordisk A/S Recent Developments
  49. 8.9 Huazhong
  50. 8.9.1 Huazhong Company Information
  51. 8.9.2 Huazhong Business Overview
  52. 8.9.3 Huazhong Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Huazhong Oral Contraceptive Drugs Product Portfolio
  54. 8.9.5 Huazhong Recent Developments
  55. 8.10 Gedeon Richter
  56. 8.10.1 Gedeon Richter Company Information
  57. 8.10.2 Gedeon Richter Business Overview
  58. 8.10.3 Gedeon Richter Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Gedeon Richter Oral Contraceptive Drugs Product Portfolio
  60. 8.10.5 Gedeon Richter Recent Developments
  61. 8.11 Actavis
  62. 8.11.1 Actavis Company Information
  63. 8.11.2 Actavis Business Overview
  64. 8.11.3 Actavis Oral Contraceptive Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Actavis Oral Contraceptive Drugs Product Portfolio
  66. 8.11.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Contraceptive Drugs Value Chain Analysis
  2. 9.1.1 Oral Contraceptive Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Contraceptive Drugs Production Mode & Process
  6. 9.2 Oral Contraceptive Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Contraceptive Drugs Distributors
  9. 9.2.3 Oral Contraceptive Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst